As far as the pancreas is
concerned, researchers found that Malassezia was present in extremely high
numbers in samples from pancreatic cancer patients. In fact, it appears that the
fungi may drive the growth of tumors by way of a cascade of events involving
inflammation and the immune system. Researchers discovered that in mice and
humans with pancreatic cancer the fungi multiply 3,000 times more than in
healthy tissue. The fungi can also make pancreatic tumors grow bigger.
The more scientists learn about the microorganisms that inhabit our bodies, the more they concur that a tumor’s “microenvironment” is just as important as the genetic factors driving its growth. As one researcher remarked, “We have to move from thinking about tumor cells alone to thinking of the whole neighborhood that the tumor lives in.”
The more scientists learn about the microorganisms that inhabit our bodies, the more they concur that a tumor’s “microenvironment” is just as important as the genetic factors driving its growth. As one researcher remarked, “We have to move from thinking about tumor cells alone to thinking of the whole neighborhood that the tumor lives in.”
These new findings may spur new
developments in treating people with pancreatic cancer. For one thing, the
presence of the fungi can serve as a biomarker for who might be at risk. At
some point, anti-fungal treatments can be tried. In mice, an antifungal drug
got rid of the fungi and kept tumors from developing. However, nobody is ready
to begin administering anti-fungal treatments to people. The interaction
between microbes and their hosts is very complex, and anti-fungal medications
can have side effects. More experimentation is needed before pancreatic cancer
patients will reap the benefits of this research. It sure sounds promising to
me.
For an introduction to this blog, see I Just Say No; for a list of blog topics, click the Topics tab.
For an introduction to this blog, see I Just Say No; for a list of blog topics, click the Topics tab.
No comments:
Post a Comment